80 related articles for article (PubMed ID: 22925602)
1. Dual effects of N-acetyl-L-cysteine dependent on NQO1 activity: suppressive or promotive of 9,10-phenanthrenequinone-induced toxicity.
Toyooka T; Shinmen T; Aarts JM; Ibuki Y
Toxicol Appl Pharmacol; 2012 Nov; 264(3):404-12. PubMed ID: 22925602
[TBL] [Abstract][Full Text] [Related]
2. Facilitation of 9,10-phenanthrenequinone-elicited neuroblastoma cell apoptosis by NAD(P)H:quinone oxidoreductase 1.
Matsunaga T; Kamase K; Takasawa H; Yamaji Y; Endo S; El-Kabbani O; Ikari A
Chem Biol Interact; 2018 Jan; 279():10-20. PubMed ID: 29108775
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
[TBL] [Abstract][Full Text] [Related]
4. L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells.
Matsunaga T; Kamiya T; Sumi D; Kumagai Y; Kalyanaraman B; Hara A
Free Radic Biol Med; 2008 Mar; 44(6):1191-202. PubMed ID: 18206670
[TBL] [Abstract][Full Text] [Related]
5. Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells.
Matsunaga T; Arakaki M; Kamiya T; Endo S; El-Kabbani O; Hara A
Chem Biol Interact; 2009 Sep; 181(1):52-60. PubMed ID: 19442656
[TBL] [Abstract][Full Text] [Related]
6. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1.
Tan AS; Berridge MV
Free Radic Biol Med; 2010 Feb; 48(3):421-9. PubMed ID: 19932748
[TBL] [Abstract][Full Text] [Related]
7. Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
Matsunaga T; Morikawa Y; Haga M; Endo S; Soda M; Yamamura K; El-Kabbani O; Tajima K; Ikari A; Hara A
Toxicol Appl Pharmacol; 2014 Jul; 278(2):180-9. PubMed ID: 24813866
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of NAD(P)H:quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells.
Nishiyama T; Izawa T; Usami M; Ohnuma T; Ogura K; Hiratsuka A
Biochem Biophys Res Commun; 2010 Apr; 394(3):459-63. PubMed ID: 20035715
[TBL] [Abstract][Full Text] [Related]
9. Effect of N-acetyl-L-cysteine on ROS production and cell death caused by HEMA in human primary gingival fibroblasts.
Spagnuolo G; D'Antò V; Cosentino C; Schmalz G; Schweikl H; Rengo S
Biomaterials; 2006 Mar; 27(9):1803-9. PubMed ID: 16289659
[TBL] [Abstract][Full Text] [Related]
10. Role of NADPH cytochrome P450 reductase in activation of RH1.
Begleiter A; Leith MK; Patel D; Hasinoff BB
Cancer Chemother Pharmacol; 2007 Oct; 60(5):713-23. PubMed ID: 17256129
[TBL] [Abstract][Full Text] [Related]
11. Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1.
Foppoli C; De Marco F; Blarzino C; Perluigi M; Cini C; Coccia R
Int J Biochem Cell Biol; 2005 Apr; 37(4):852-63. PubMed ID: 15694844
[TBL] [Abstract][Full Text] [Related]
12. Dual pathways of p53 mediated glucolipotoxicity-induced apoptosis of rat cardiomyoblast cell: activation of p53 proapoptosis and inhibition of Nrf2-NQO1 antiapoptosis.
Wang HJ; Lee EY; Han SJ; Kim SH; Lee BW; Ahn CW; Cha BS; Lee HC
Metabolism; 2012 Apr; 61(4):496-503. PubMed ID: 22154326
[TBL] [Abstract][Full Text] [Related]
13. The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger.
Zhu H; Jia Z; Mahaney JE; Ross D; Misra HP; Trush MA; Li Y
Cardiovasc Toxicol; 2007; 7(3):202-11. PubMed ID: 17901563
[TBL] [Abstract][Full Text] [Related]
14. Aldo-keto reductase 1C15 as a quinone reductase in rat endothelial cell: its involvement in redox cycling of 9,10-phenanthrenequinone.
Matsunaga T; Shinoda Y; Inoue Y; Shimizu Y; Haga M; Endo S; El-Kabbani O; Hara A
Free Radic Res; 2011 Jul; 45(7):848-57. PubMed ID: 21623689
[TBL] [Abstract][Full Text] [Related]
15. In vivo relevance of two critical levels for NAD(P)H:quinone oxidoreductase (NQO1)-mediated cellular protection against electrophile toxicity found in vitro.
de Haan LH; Pot GK; Aarts JM; Rietjens IM; Alink GM
Toxicol In Vitro; 2006 Aug; 20(5):594-600. PubMed ID: 16314070
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
[TBL] [Abstract][Full Text] [Related]
17. Biochemical, cytotoxic, and genotoxic effects of ES936, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, in cellular systems.
Dehn DL; Siegel D; Swann E; Moody CJ; Ross D
Mol Pharmacol; 2003 Sep; 64(3):714-20. PubMed ID: 12920209
[TBL] [Abstract][Full Text] [Related]
18. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death.
Zafar KS; Inayat-Hussain SH; Siegel D; Bao A; Shieh B; Ross D
Toxicol Lett; 2006 Oct; 166(3):261-7. PubMed ID: 16978807
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
